{"id":"https://openalex.org/W7224366003","doi":"https://doi.org/10.51731/cjht.2026.1555","title":"Gilteritinib (Xospata)","display_name":"Gilteritinib (Xospata)","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224366003","doi":"https://doi.org/10.51731/cjht.2026.1555"},"language":"en","primary_location":{"id":"doi:10.51731/cjht.2026.1555","doi":"https://doi.org/10.51731/cjht.2026.1555","is_oa":true,"landing_page_url":"https://doi.org/10.51731/cjht.2026.1555","pdf_url":"https://canjhealthtechnol.ca/index.php/cjht/article/download/PC0444r/PC0444r","source":{"id":"https://openalex.org/S4210215418","display_name":"Canadian Journal of Health Technologies","issn_l":"2563-6596","issn":["2563-6596"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Health Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://canjhealthtechnol.ca/index.php/cjht/article/download/PC0444r/PC0444r","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114394934","display_name":"CDA-AMC","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"CDA-AMC","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5114394934"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85008357,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"10","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.02930000051856041,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":1.0},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8550000190734863},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/relapsed-refractory-leukemia","display_name":"relapsed/refractory leukemia","score":0.875},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9459999799728394},{"id":"https://openalex.org/keywords/clinical-effectiveness","display_name":"clinical effectiveness","score":0.9660000205039978}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.7962999939918518},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7595999836921692},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5303999781608582},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4318999946117401},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3928999900817871},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.375900000333786},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3109000027179718},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.30399999022483826},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2752000093460083},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2303999960422516}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.51731/cjht.2026.1555","doi":"https://doi.org/10.51731/cjht.2026.1555","is_oa":true,"landing_page_url":"https://doi.org/10.51731/cjht.2026.1555","pdf_url":"https://canjhealthtechnol.ca/index.php/cjht/article/download/PC0444r/PC0444r","source":{"id":"https://openalex.org/S4210215418","display_name":"Canadian Journal of Health Technologies","issn_l":"2563-6596","issn":["2563-6596"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Health Technologies","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.51731/cjht.2026.1555","doi":"https://doi.org/10.51731/cjht.2026.1555","is_oa":true,"landing_page_url":"https://doi.org/10.51731/cjht.2026.1555","pdf_url":"https://canjhealthtechnol.ca/index.php/cjht/article/download/PC0444r/PC0444r","source":{"id":"https://openalex.org/S4210215418","display_name":"Canadian Journal of Health Technologies","issn_l":"2563-6596","issn":["2563-6596"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Health Technologies","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224366003.pdf","grobid_xml":"https://content.openalex.org/works/W7224366003.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1963777403","https://openalex.org/W2020304948","https://openalex.org/W2052978273","https://openalex.org/W2129615499","https://openalex.org/W2172033819","https://openalex.org/W2798041034","https://openalex.org/W2909346948","https://openalex.org/W2917823598","https://openalex.org/W3194750008","https://openalex.org/W4284884567","https://openalex.org/W4307845247","https://openalex.org/W4310342538","https://openalex.org/W4386085936","https://openalex.org/W4389624712","https://openalex.org/W4391752105","https://openalex.org/W4396577067","https://openalex.org/W4406120289","https://openalex.org/W4407009995","https://openalex.org/W4417342517"],"related_works":["https://openalex.org/W3011919266","https://openalex.org/W3119913436","https://openalex.org/W2948801087","https://openalex.org/W6939244339","https://openalex.org/W3132740458","https://openalex.org/W4385698031","https://openalex.org/W3015514897","https://openalex.org/W2970993279","https://openalex.org/W4254031127","https://openalex.org/W3202193094"],"abstract_inverted_index":{"Reimbursement":[0],"reviews":[1],"are":[2],"comprehensive":[3],"assessments":[4,25],"of":[5,18,35,45,59],"the":[6,32,43],"clinical":[7],"effectiveness":[8],"and":[9,15,39],"cost-effectiveness,":[10],"as":[11,13],"well":[12],"patient":[14],"clinician":[16],"perspectives,":[17],"a":[19,72],"drug":[20,22],"or":[21,65],"class.":[23],"The":[24,57],"inform":[26],"nonbinding":[27],"recommendations":[28],"that":[29],"help":[30],"guide":[31],"reimbursement":[33],"decisions":[34],"Canada\u2019s":[36],"federal,":[37],"provincial,":[38],"territorial":[40],"governments,":[41],"with":[42,71],"exception":[44],"Quebec.":[46],"This":[47],"review":[48],"assesses":[49],"gilteritinib":[50],"(Xospata),":[51],"40":[52],"mg,":[53],"tablet,":[54],"oral.":[55],"Indication:":[56],"treatment":[58],"adult":[60],"patients":[61],"who":[62],"have":[63],"relapsed":[64],"refractory":[66],"acute":[67],"myeloid":[68],"leukemia":[69],"(AML)":[70],"FMS-like":[73],"tyrosine":[74],"kinase":[75],"3":[76],"(FLT3)":[77],"mutation.":[78]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}